4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-13-031061
Director bought 120,000 shares
From the SEC's structured data for this filing
Trades in this filing
LICHTINGER PEDRO · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2013-06-04 | Purchase : show line 1 in the form | +120,000 | 126,250 | D |
| Open-market purchases · 120,000 sh | ||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-06-04 | Purchase : show line 2 in the form Option to Purchase Common Shares | +30,000 | $5.00 | 2018-06-04 | 30,000 | 30,000 | D |
Loading xslF345X03/doc4.xml…